新型光敏剂BF01光动力治疗人肝癌的实验研究
DOI:
CSTR:
作者:
作者单位:

(上海百菲生物医药科技有限公司,上海 201203)

作者简介:

谷长维男,硕士,医药工程师,主要从事光敏剂治疗癌症机制 研究.

通讯作者:

中图分类号:

基金项目:


Experimental study on human liver cancer by new photosensitizer BF01photodynamic therapy
Author:
Affiliation:

(Shanghai baifei biomedical technology co.Ltd.,Shanghai 201203,China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    探讨光敏剂BF01光动力对人肝癌细胞株bel- 7402体外杀伤效应和体内抑瘤效 应及其作用机制。CCK-8法检测同一激光强度不同给药浓度的(0、0.8、3.2 μmol·L-1)BF01光动力(激光剂量2.4 J/cm2,光照时间 :1min/well,激光波长652 nm)处 理下对bel-7402细胞的抑制率和IC50,流式 细 胞术检测bel-7402细胞死亡方式,DAPI染色 观察细胞凋亡特征,光动力后检测bel-7402活性氧、共聚焦显微镜 观察亚细胞定位,建立 裸鼠人肝癌细胞模型,绘制肿瘤生长曲线,观察治疗效果。BF01-PDT治疗组能明显 抑制bel-7402肿瘤细胞增殖,BF01的浓度为6.4 μmol·L-1时,其杀伤率到86%,半数杀伤 浓度IC50 μmol·L-1,检测细 胞死亡方式主要是以晚期凋亡为主,BF01-PDT作用 bel-7402细胞后,经DAPI染色细胞核的形态呈现出凋亡的特征,活 性氧水平随给药浓度 增加而增加,亚细胞定位在线粒体,体内实验表明BF01-PDT可以明显抑制人肝癌肿瘤生长 。光敏剂BF01介导的光动力疗法对人肝癌细胞及小鼠体内肿瘤生长抑制作用明显,光 动力疗法以细胞凋亡为主,其机制可能与光敏剂BF01定位在肿瘤细胞的线粒体,增加 bel-7402细胞中ROS含量有关。

    Abstract:

    To investigate the killing effect ofphotodynamictheraphy(P DT)mediated by photosensitizerBF01on human hepatocellular carcinoma cell line bel-7402in v it ro and the tumor suppressor effect in vivo and its action mechanism.CCK-8methodw as employed to determine the same laser intensity and different drug concentrations(0、0.8、1.6、3.2、6.4μmol·L-1;laser doses 2.4J/cm2,illumination t ime:1min/well,laser wavelength of 652nm) BF01-PDT on the proliferation of bel-7402and IC50,Cell apoptosis and necrosis we re measured by DAPI staining and flow cytometry with AnnexinV-FITC /PI double staining,RO S of bel-7402human hepatocellular carcinoma cells was detected.Confocal microscopy a ssaywas used to observe BF01subcellular localization on bel-7402cells.A bel-7402-bearin g NU /NU mice model wasestablished,and the tumor volume was measured todraw the growth curve.The t umor growth curve was plotted and the therapeutic effect was observed.CCK8assay sh owed that BF01-PDT could significantly inhibit bel-7402cell.When the concentration o f BF01was 6.4μmol·L-1,the killing rate was 86%,and half of the killin g concentration IC50was 2.46μmol-1.BF01subcellular localizationwas tightly cellular correlated,it mainly localized in mitochondria in bel-7402.The detection of cell death was mainly based on la t e apoptosis,DAPI staining and flow cytometric analysis showed that BF01-PDT could induce apoptos is of bel-7402. ROS levels of bel-7402human hepatocellular carcinoma cells were increased afte r BF01-PDT.The in vivo experiments demonstratedthat BF01-PDT significantly inhibited the growt hof bel-7402tumor.BF01-mediated PDT has a significant lethal effect on bel-7402cells invitro and in vivo.The lethal effect of PDT on cancercells is shown in the apoptosis a nd can be attributed to BF01subcellular localization in mitochondria in bel-7402,and th e increased ROS levels of bel-7402human hepatocellular carcinomacells.

    参考文献
    相似文献
    引证文献
引用本文

谷长维.新型光敏剂BF01光动力治疗人肝癌的实验研究[J].光电子激光,2019,30(8):884~890

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2019-03-28
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-10-08
  • 出版日期:
文章二维码